Skip to content

Research on Individualized Precision Regulation Methods and Assessment Strategies of Transcranial Magnetic Stimulation for Alzheimer's Disease

Research on Individualized Precision Regulation Methods and Assessment Strategies of Transcranial Magnetic Stimulation for Alzheimer's Disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113082
Enrollment
Unknown
Registered
2025-11-24
Start date
2023-10-08
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

Sham group:The sham stimulation group received identical parameter settings as the rTMS group, but used a dedicated sham coil that does not generate an effective magnetic field in the cortex.
DLPFC-rTMS:Received 14 consecutive days of rTMS intervention, with stimulation intensity set at 90% of resting motor threshold, frequency of 20 Hz, 2 s per train, 28 s inter-train interval, 40 trains
DLPFC-iTBS:iTBS stimulation was applied to the left dorsolateral prefrontal cortex. The stimulation intensity was set at 70% of the resting motor threshold, using a burst pattern with three pulses per
a total of 600 pulses were delivered per session, lasting 190 s. Three sessions were performed daily, with 15-minute intervals between each session.

Sponsors

Tianjin Huanhu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: Recruitment criteria for AD subjects are: 1. Age 50–85 years, meeting NIA-AA diagnostic criteria for Alzheimer’s disease (AD); 2. Mini-Mental State Examination (MMSE) score between 10 and 27; 3. Mild to moderate AD, defined by Clinical Dementia Rating (CDR) <= 2; 4. Patients and their families possess legal capacity to understand the study and provide informed consent. All diagnoses and enrollments were determined by senior neurologists.

Exclusion criteria

Exclusion criteria: Exclusion criteria for AD subjects were: 1. History of epilepsy or other neurological disorders; 2. Severe depression with Hamilton Depression Scale (HAMD) score >20; 3. Presence of visual or auditory impairments; 4. History of any severe chronic systemic disease, brain injury, or alcohol/substance abuse; 5. Presence of any contraindications to TMS.

Design outcomes

Primary

MeasureTime frame
Mini-Mental State Examination;Montreal Cognitive Assessment;

Secondary

MeasureTime frame
Electroencephalography (EEG);Magnetic Resonance Imaging (MRI);Blood biomarker;Other scales: Activities of Daily Living (ADL) Scale, Hamilton Depression Rating Scale (HAMD/HDRS), Auditory Verbal Learning Test (AVLT), Digit Span Test (DST), Boston Naming Test (BNT), Verbal Fluency Test (VFT), Stroop Color-Word Test (SCWT), and Trail Making Test (TMT).;

Countries

China

Contacts

Public ContactYin Shaoya

Tianjin Huanhu Hospital

yinsy@163.com+86 186 2213 9285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026